The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence
- PMID: 1427073
- DOI: 10.1101/gad.6.11.2077
The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence
Abstract
Among eukaryotic transcription trans-activators, the human immunodeficiency virus type 1 (HIV-1) Tat protein is exceptional in that its target site TAR is an RNA rather than a DNA sequence. Here, we confirm that fusion of Tat to the RNA-binding domain of the HIV-1 Rev protein permits the efficient activation of an HIV-1 long terminal repeat (LTR) promoter in which critical TAR sequences have been replaced by RNA sequences derived from the HIV-1 Rev response element (RRE). An RRE target sequence as small as 13 nucleotides is shown to form an effective in vivo target for Rev binding. More important, a fusion protein consisting of Rev attached to the VP16 transcription activation domain was also observed to efficiently activate the HIV-1 LTR from this nascent RNA target. These data demonstrate that trans-activation of transcription by acidic activation domains does not require a stable interaction with the promoter DNA and suggest that VP16, like Tat, can act on steps subsequent to the formation of the HIV-1 LTR preinitiation complex. The finding that the activation domains of VP16 and Tat are functionally interchangeable raises the possibility that these apparently disparate viral trans-activators may nevertheless act via similar mechanisms.
Similar articles
-
Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells.J Virol. 1993 Sep;67(9):5617-22. doi: 10.1128/JVI.67.9.5617-5622.1993. J Virol. 1993. PMID: 8350414 Free PMC article.
-
Human immunodeficiency virus type 1 Rev activation can be achieved without Rev-responsive element RNA if Rev is directed to the target as a Rev/MS2 fusion protein which tethers the MS2 operator RNA.J Virol. 1992 Dec;66(12):7469-80. doi: 10.1128/JVI.66.12.7469-7480.1992. J Virol. 1992. PMID: 1433526 Free PMC article.
-
Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein.Nature. 1990 Jun 14;345(6276):640-2. doi: 10.1038/345640a0. Nature. 1990. PMID: 2190099
-
RNA-sequence-mediated gene regulation in HIV-1.Infect Agents Dis. 1994 Apr-Jun;3(2-3):68-76. Infect Agents Dis. 1994. PMID: 7812657 Review.
-
Regulation of expression of human immunodeficiency virus.New Biol. 1990 Jan;2(1):20-31. New Biol. 1990. PMID: 2078551 Review.
Cited by
-
Phosphatase PPM1A negatively regulates P-TEFb function in resting CD4(+) T cells and inhibits HIV-1 gene expression.Retrovirology. 2012 Jun 22;9:52. doi: 10.1186/1742-4690-9-52. Retrovirology. 2012. PMID: 22727189 Free PMC article.
-
The R region found in the human foamy virus long terminal repeat is critical for both Gag and Pol protein expression.J Virol. 2001 Aug;75(15):6817-24. doi: 10.1128/JVI.75.15.6817-6824.2001. J Virol. 2001. PMID: 11435560 Free PMC article.
-
Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells.J Virol. 1993 Sep;67(9):5617-22. doi: 10.1128/JVI.67.9.5617-5622.1993. J Virol. 1993. PMID: 8350414 Free PMC article.
-
RNA-targeted activators, but not DNA-targeted activators, repress the synthesis of short transcripts at the human immunodeficiency virus type 1 long terminal repeat.J Virol. 1997 Feb;71(2):910-7. doi: 10.1128/JVI.71.2.910-917.1997. J Virol. 1997. PMID: 8995607 Free PMC article.
-
Viral transactivators specifically target distinct cellular protein kinases that phosphorylate the RNA polymerase II C-terminal domain.Nucleic Acids Res. 1996 Feb 1;24(3):501-8. doi: 10.1093/nar/24.3.501. Nucleic Acids Res. 1996. PMID: 8602364 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources